Alcon Inc. (LON:0A0D)
70.36
+0.50 (0.72%)
At close: Jun 27, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Implantables | 1.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Implantables Growth | 3.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumables | 2.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumables Growth | 5.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Equipment/Other | 886.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Equipment/Other Growth | -2.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contact Lenses | 2.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contact Lenses Growth | 6.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ocular Health | 1.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ocular Health Growth | 1.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other | 75.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Growth | 1.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other | 75.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Growth | 1.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Other | -45.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Segment Contribution | 1.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Segment Contribution Growth | -2.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vision Care Segment Contribution | 962.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vision Care Segment Contribution Growth | 17.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Contribution | -1.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Contribution Growth | -23.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -45.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -45.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Total Other | 75.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Growth | 1.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 4.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 2.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | 5.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 4.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other | 75.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Growth | 1.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Surgical Constant Currency Sales Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vision Care Constant Currency Sales Growth | 7.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Constant Currency Sales Growth | 6.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|